alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
IN THE COURT OF CRIMINAL APPEALS

OF TEXAS

NO. WR-95,426-01

EX PARTE RICHARD LEE HOOPER, Applicant

ON APPLICATION FOR A WRIT OF HABEAS CORPUS

CAUSE NO. 1487418-A IN THE 184TH DISTRICT COURT FROM HARRIS COUNTY

Per curiam. KELLER, P.J. filed a dissenting opinion joined by YEARY, KEEL, and

SLAUGHTER, JJ. YEARY, J. filed a dissenting opinion.

O P I N I O N

Applicant pleaded guilty, was convicted of possession of a controlled substance, and

sentenced to three years’ imprisonment in this cause. Applicant filed this application for a writ of

habeas corpus in the county of conviction, and the district clerk forwarded it to this Court. SeeTEX.

CODE CRIM. PROC. art. 11.07.

Applicant contends that his plea was involuntary because he was not aware of a lab report

showing that he possessed less than the required four grams of controlled substance to sustain the

charge. Based on the record, the trial court has determined that Applicant’s plea was involuntary.

Relief is granted. Ex parte Mable, 443 S.W.3d 129 (Tex. Crim. App. 2014), Brady v. United

States, 397 U.S. 742 (1970). The judgment in cause number 148741801010 in the 184th District
2

Court of Harris County is set aside, and Applicant is remanded to the custody of the Sheriff of Harris

County to answer the charge as set out in the indictment. The trial court shall issue any necessary

bench warrant within ten days from the date of this Court’s mandate.

Copies ofthis opinion shall be sent to the Texas Department of Criminal Justice–Correctional

Institutions Division and the Board of Pardons and Paroles.

Delivered: March 6, 2024

Do not publish
Exhibit 33.2


[LOGO]                                                  Wells Fargo Bank, N.A.
                                                        Document Custody
                                                        1015 10th Avenue SE
                                                        Minneapolis, MN 55414

                                                        Appendix I

          ASSESSMENT OF COMPLIANCE WITH APPLICABLE SERVICING CRITERIA

Corporate Trust Services division of Wells Fargo Bank, National Association (the
"Company") is responsible for assessing compliance with the servicing criteria
set forth in Item 1122(d) of Regulation AB promulgated by the Securities and
Exchange Commission. The Company has determined that the servicing criteria are
applicable in regard to the servicing platform for the period as follows:

Platform: Publicly-issued (i.e., transaction-level reporting required under the
Securities Exchange Act of 1934, as amended) residential mortgage-backed
securities and commercial mortgage-backed securities issued on or after January
1, 2006, for which the Company provides document custody services, excluding any
publicly issued transactions issued by any government sponsored entity (the
"Platform").

Applicable Servicing Criteria: The servicing criteria set forth in Item
1122(d)(4)(i) and 1122(d)(4)(ii), in regard to the activities performed by the
Company with respect to the Platform (the "Applicable Servicing Criteria"). The
Company has determined that all other servicing criteria set forth in Item
1122(d) are not applicable to the Platform.

Period: Twelve months ended December 31, 2006 (the "Period").

With respect to the Platform, the Company provides the following assessment of
compliance with respect to the Applicable Servicing Criteria:

1. The Company is responsible for assessing the Company's compliance with the
Applicable Servicing Criteria as of and for the Period.

2. The Company has assessed compliance with the Applicable Servicing Criteria.
In performing this assessment, the Company used the criteria set forth by the
Securities and Exchange Commission in paragraph (d) of Item 1122 of Regulation
AB.

3. Based on such assessment, as of and for the Period, the Company has complied,
in all material respects with the Applicable Servicing Criteria.

KPMG LLP, a registered public accounting firm, has issued an attestation report
with respect to the Company's assessment of compliance as of and for the Period.


                                WELLS FARGO BANK, NATIONAL ASSOCIATION

                                By:    /s/ Shari L. Gillund
                                   -----------------------------------
                                       Shari L. Gillund

                                Its:   Senior Vice President

                                Dated: March 1, 2007
Exhibit
32.2













CERTIFICATION
OF CO-CHIEF EXECUTIVE OFFICER


PURSUANT
TO 18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002








I, Mark
Gatto, Co-Chief Executive Officer and Co-President of ICON Capital Corp.,
the Manager of the Registrant, in connection with the Annual Report of ICON
Leasing Fund Twelve, LLC (the “LLC”) on Form 10-K for the year ended December
31, 2009, as filed with the Securities and Exchange Commission on the date
hereof (the “Annual Report”) certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:





1.
            The
      Annual Report fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of
      1934, as amended; and





2.
            The
      information contained in the Annual Report fairly presents, in all
      material respects, the  financial condition and results of operations
      of the LLC.








Date:
March 30, 2010





/s/Mark
Gatto


Mark
Gatto


Co-Chief
Executive Officer and Co-President


ICON
Capital Corp.


Manager
of ICON Leasing Fund Twelve, LLC
#### The State v. Kraner *et al.*

Appeal: criminal case : no exceptions or argument : affirmed.

*Appeal from Wapello District Court.*— Hon. Charles D. Leggett, Judge.

Filed, May 23, 1888.

The defendants were indicted and convicted for maintaining a nuisance by keeping a place for the unlawful sale of intoxicating liquors, and now appeal to this court.

No appearance for the appellants.

*A. J. Baker,*Attorney General, for the State.

*761Beck, J.

The cause was submitted to us for decision without exceptions or argument in any form for the appellants. The record shows that questions *involving*the constitutionality of the statute under which the indictment was found, and other questions usually raised in trials for offenses of this character, were raised by objections in the court below, and were ruled upon in accord with frequent prior decisions of this court. It is needless to consider that question here.

We have, as we are required by the statute, examined the record of the case before us, and have discovered no error therein. We are not required to imagine possible objections and present reasons supporting the rulings of the district court as against them. The judgment of the district court is

Affirmed.
EXHIBIT 23.2





INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT











We consent to the incorporation by reference in the Registration Statement of Bridgeline Digital, Inc. on Form S-8 (No. 333-170819) of our report dated December 28, 2009, pertaining to the consolidated financial statements of Bridgeline Digital, Inc. (formally Bridgeline Software, Inc.) as of September 30, 2009 and for the year then ended, which appears in the Annual Report on Form 10-K of Bridgeline Digital, Inc. for the year ended September 30, 2010.








/s/ UHY LLP





Boston, Massachusetts


December 29, 2010
#### AMERIJET INTERNATIONAL, INC., Petitioner v. United States DEPARTMENT OF HOMELAND SECURITY, et al., Respondents

No. 14-1087

September Term, 2016

United States Court of Appeals, District of Columbia Circuit.

Filed: 12/29/2016

TSA-SD 1544-11-04B

Joan Marie Canny, Esquire, Amerijet International, Inc., Fort Lauderdale, FL, for Petitioner.

Jeffrey Eric Sandberg, Attorney, Sharon Swingle, U.S. Department of Justice (DOJ), Civil Division, Appellate Staff, Washington, DC, for Respondents.

ORDER

Upon consideration of the stipulation of voluntary dismissal, .it is

ORDERED that the Clerk note on the docket that this case is dismissed. No mandate will issue.
EXHIBIT 32.1



CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350



In connection with the Quarterly Report on Form 10-QSB of American Wagering, Inc. (the Company) for the quarter ended July 31, 2005, as filed
with the Securities and Exchange Commission (the Report), each of us certifies as of the date hereof, solely for the purposes of Title 18, Chapter 63, Section 1350 of the United States Code, to our respective knowledge, that:



| | (1) | the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and
| | --- | -------------------------------------------------------------------------------------------------------------------------------------



| | (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods
indicated.
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



A signed original of this written
statement, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement, has been provided to the Company and will be retained by the Company
and furnished to the Securities and Exchange Commission or its staff upon request.



|                   |  |  |  |                       |  |                                                                                                   
|------------------ |  |  |  | --------------------- |  | --------------------------------------------------------------------------------------------------
|Date:              |  |  |  |                       |  |                                                                                                   
|                   |  | 
|September 14, 2005 |  |  |  | /s/ Victor J. Salerno
|                   |  |  |  | By:                   |  | Victor J. Salerno                                                                                 
|                   |  |  |  | Title:                |  | President, Chief Executive Officer, Chief Operating Officer and Chairman of the Board of Directors



|                   |  |  |  |                          |  |                                                           
|------------------ |  |  |  | ------------------------ |  | ----------------------------------------------------------
|Date:              |  |  |  |                          |  |                                                           
|                   |  | 
|September 14, 2005 |  |  |  | /s/ Timothy F. Lockinger
|                   |  |  |  | By:                      |  | Timothy F. Lockinger                                      
|                   |  |  |  | Title:                   |  | Chief Financial Officer, Secretary, Treasurer and Director
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

# TIME AND DATE:

Notice is hereby given, pursuant to the provisions of the Government in the Sunshine Act, Public Law 94-409, that the Securities and Exchange Commission will hold an Open Meeting on Wednesday, March 9, 2022 at 10 a.m.

# PLACE:

                        The meeting will be webcast on the Commission's website at                         *www.sec.gov.*

# STATUS:

                        The meeting will begin at 10 a.m. (ET) and will be open to the public via webcast on the Commission's website at                         *www.sec.gov.*

# MATTERS TO BE CONSIDERED:

1. The Commission will consider whether to propose amendments regarding cybersecurity risk management, strategy, governance, and incident disclosure.

# CONTACT PERSON FOR MORE INFORMATION:

For further information and to ascertain what, if any, matters have been added, deleted or postponed, please contact Vanessa A. Countryman from the Office of the Secretary at (202) 551-5400.

*Authority:*5 U.S.C. 552b.                    

Dated: March 9, 2022.

Vanessa A. Countryman,

Secretary.

[FR Doc. 2022-04830 Filed 3-3-22; 11:15 am]

BILLING CODE 8011-01-P
[Federal Register Volume 87, Number 40 (Tuesday, March 1, 2022)]
[Notices]
[Page 11444]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04261]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Strategic 
Business Initiatives Unit, Office of the Chief Operating Officer, CDC, 
pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)- RFA-CK-22-001, Investigation of 
Monkeypox and Other Zoonotic Diseases in the Democratic Republic of the 
Congo (DRC); RFA-CK-22-002, Technological Advancement of Global Rabies 
Surveillance and Control; and RFA-CK-22-004, Optimization and 
Standardization of Methods to Suppress Ixodes scapularis and Disrupt 
Enzootic Pathogen Transmission in Settings Posing an Elevated Risk to 
Humans.
    Date: April 28, 2022.
    Time: 10:00 a.m.-5:00 p.m. (EDT).
    Place: Teleconference, Centers for Disease Control and Prevention, 
Room 1080, 8 Corporate Square Blvd., Atlanta, GA 30329.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329, (404) 718-8833, <a href="/cdn-cgi/l/email-protection#5a3d3b343e3f282935341a393e39743d352c"><span class="__cf_email__" data-cfemail="f097919e949582839f9eb0939493de979f86">[email protected]</span></a>.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-04261 Filed 2-28-22; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
ATTACHMENT HEADER SHEET

Attachment Number 004 Attachment Name CAS 73361-29-2 Manufacturing Process and Impurity Profile Associated PMN Section Number Pt.I, Sec.B, 3. Contains CBI Report Number Sanitized Version

# All CBI has been removed
#### Schaben v. Brunning & Son.

1. Appeal: evidence to support verdict. "Where the evidence is conflicting, this court will not interfere with a verdict on the ground that it is.not sustained by the evidence.

2. Consideration : settlement op claims. A settlement of conflicting accounts is a valid consideration for an agreement to pay a balance found due one of the parties.

*Appeal from Pollc District Court.*— Hour. W. F. Conrad, Judge.

Filed, March 9, 1888.

Action to recover for goods sold and delivered. Defendants admit the claim of plaintiff, and plead counter-claims. Verdict and judgment for defendants. The plaintiff appeals,

*Macomb er & Son,*for appellant.

*B. M. Betzer*and *J. M. Drees,*for appellees.

Robinson, J.

i. appeal: evideuce to support verdict, I. The chief controversy in this case is over the liability of plaintiff for certain goods sold and delivered, but which, he insists, . - . , , . . were never purchased or received by him, and for which he never agreed to pay. The evidence tends to show that these goods were, in fact, sold and charged to a brother of appellant. It appears that appellant and this brother were for several years engaged in the milling business under the firm name of Schaben Bros. While they were so engaged, they sold to defendants merchandise to the amount of $1,045.76. During the same time, defendants sold to Schaben Bros, lumber and wheat to a considerable amount. They had given their note to one of the defendants. The goods in controversy had been sold, and defendants seemed to *103claim that both plaintiff and his brother were liable for their price. In January, 1884, all the members of the firm of Sehaben Bros, and C. Brunning & Son met and attempted to settle their respective claims. It is insisted by defendants that this was accomplished ; that the claim for the goods in controversy was included; and that a balance of $245.36 was found, and agreed 'by all of the persons aforesaid to be due the defendants. It is further claimed that plaintiff and his brother agreed to give their note at a later date for this agreed balance. The note was not given, and the settlement and agreement are denied by plaintiff. The evidence is conflicting, and that given on the part of the defendants is not altogether satisfactory. But we are not prepared to say that there was not sufficient evidence to sustain the verdict.

2 considerament:oíertle" claims. II. Appellant insists that there was no consideration for his alleged promise to pay the balance found to ^e due the defendant on settlement. If the1'© was a settlement of accounts and claims betweén the parties, the agreement as to what were the rights and liabilities of the several parties would be a sufficient consideration for a promise to pay the balance found to be due the defendants. The failure to give the note as agreed would not defeat the settlement.

III. It is claimed by appellant that the court below erred in certain rulings made during the introduction of evidence on the trial. W e do not think this claim is well founded.

Affirmed.
[Federal Register Volume 87, Number 43 (Friday, March 4, 2022)]
[Notices]
[Pages 12467-12468]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04622]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as

[[Page 12468]]

amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK KUH U2C/TL1 
Special Emphasis Panel.
    Date: March 23-25, 2022.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institutes of Health/NIDDK, 6707 Democracy 
Blvd., Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Peter J. Kozel, Ph.D., Chief, Training and 
Mentored Research Section, Scientific Review Branch, Division of 
Extramural Activities, 6707 Democracy Blvd., Room 7009, Bethesda, MD 
20892, <a href="/cdn-cgi/l/email-protection#72191d08171e02321f131b1e5c1c1b1a5c151d04"><span class="__cf_email__" data-cfemail="3f5450455a534f7f525e56531151565711585049">[email protected]</span></a>, 301-594-4721.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: March 1, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-04622 Filed 3-3-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
14910-1

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administr-ation

14 CFR Part 39

PMIDocket N0j'\2009-1215; Directorate Identifier 2009-NM-126-AD; Amendment

39-16364; AD 2010-14-191

R1N 2120-AA64

Airworthiness Directives; Airbus Model A330-200 and -300 Series Airplanes, and

Model A340-200, -300, -500 and -600 Series Airplanes

AGENCY: Federal Aviation Administration (FAA), Department of Transportation

(DOT).

ACTION: Final rule; correction.

SUMMARY: The FAA is correcting airworthiness directive (AD) 2010-14-19, whi 1

published in the Federal Register on July 13,2010. That AD applies 10 certain Mode

A330-200 and -300 series airplanes, and Model A340-200, -300, -500 and -600 serie

airplanes. A certain service bulletin number IIINote 3 of the regulatory section is

incorrect. This document corrects that service bulletin Humber. In all other respects, e

original document remains the same.

DATES: This correction is effective [INSERT DATE OF PUBLICATION IN THE

FEDERA.L REGISTER]. The effective date of AD 20] 0-14-19 remains August] 7,2

ADDRESSES: You may examine the AD docket on the Internet at

a.m. and 5 p.m., Monday through Friday, except Federal holidays. The AD docket

contains this AD, the regulatory evaluation, any comments received, and other

inronnation. The address for the Docket Office (telephone 800-647-5527) is the

Document Management Facility, U.S. Department of Transportation, Docket Operations,

FAA Form 1360·14.1 (6-89) OFFICIAL ALE COPY ~ u.s. GOVERNr.ENT PRINTING OFFICE: 1995 - 7(>g-211